Elacestrant is recommended for patients whose cancer has worsened after at least a year of treatment with hormone therapy and CDK4/6 inhibitor.

The Independent

London

Greater London

England

United Kingdom

Daily tablet for advanced breast cancer patients set for NHS rollout

Ad Fontes Media

All Sides

Media Bias/Fact Check

Evgeny Lebedev

Shropshire Star

MNA Media

Ketley

Shropshire

A new once-a-day tablet that treats advanced breast cancer is to be rolled out on the NHS, with about 1,100 patients in England set to benefit. The final guidance on elacestrant by the National Institute for Health and Care Excellence (Nice) comes after it provisionally rejected the drug in October. The charity Breast Cancer Now welcomed the news but said it remains “deeply concerned that the system is not working in getting all secondary breast…

Jersey Evening Post

Claverley Group

Elacestrant is recommended for patients whose cancer has worsened after at least a year of treatment with hormone therapy and CDK4/6 inhibitor.  A new once-a-day tablet that treats advanced breast cancer is to be rolled out on the NHS, with about 1,100 patients in England set to benefit. The final guidance on elacestrant by the National Institute for Health and Care Excellence (Nice) comes after it provisionally rejected the drug in October. The…

perspectivemedia.com

Dr. Aditya Bardia presents real-world findings on elacestrant, demonstrating prolonged real-world progression-free survival (rwPFS) in ER+/HER2- advanced breast cancer patients across all clinically relevant subgroups, with benefits observed particularly in earlier treatment lines and in those without prior fulvestrant exposure.

onclive.com

Elacestrant real-world progression-free survival (rwPFS) of adult patients with ER+/HER2-, advanced breast cancer: a retrospective analysis using insurance claims in the United States

Since elacestrant’s emergence in the real-world setting, it has demonstrated superior efficacy outcomes compared with what the EMERALD study found.

cancernetwork.com

Elacestrant’s Real World Outcomes Improve Over Clinical Findings in Breast Cancer

Cancer

Breast Cancer

Daily tablet for advanced breast cancer patients set for NHS rollout

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics